Assessment of Transnasal Humidified Rapid-insufflation Ventilatory Exchange (THRIVE) for Maternal Pre-oxygenation

NCT ID: NCT04814628

Last Updated: 2024-07-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

1 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-02-15

Study Completion Date

2024-06-25

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The main objective of this study is to determine if the use of transnasal humidified rapid-insufflation ventilatory exchange (THRIVE) can reduce by 90 seconds the time between the entry into the operating room of the volunteer and the moment when the anaesthetic drugs are ready and when the Oxygen Reserve Index has reached a plateau value for more than 10 seconds, a moment which would therefore allow the induction of general anaesthesia, compared to the pre-oxygenation with the face mask applied by the anaesthetist alone in charge of anaesthesia.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cesarean Section Complications Pregnancy Related Anesthesia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

healthy volunteer subject

A single healthy volunteer subject will participate in the study as a model of a pregnant woman in the third trimester of pregnancy, with a functional respiratory capacity reduced by 20% thanks to elastic restraints performed under the control of functional respiratory explorations.

8 obstetric anesthesiologists will participate in the 4 scenarios;

Group Type EXPERIMENTAL

scenario 1 : pre-oxygenation with a face mask held by the anaesthetist

Intervention Type PROCEDURE

the face mask is held by the anaesthetist (reference technique) to obtain effective pre-oxygenation for Oxygen Reserve Index (ORI) which has reached a plateau value for more than 10 seconds. All the usual supplies and medicines are available and in the same place as usual.

The sequence is as follows:

1. Patient lying on the operating table, start of the stopwatch
2. Opening of the computerized anaesthesia file
3. Monitoring (ECG, non-invasive blood pressure, SaO2) of the patient
4. Preparation of the hypnotic (propofol or thiopental, as desired)
5. Preparation of curare (succinylcholine or rocuronium, as desired)
6. Pre-oxygenation of the patient with the face mask held by the participating anaesthetist
7. Waiting for an ORI which has reached a plateau value for more than 10 seconds
8. Conditions for general anaesthesia met for the participating anaesthetist
9. "End of simulation", stopwatch stop

scenario 2: one anaesthetist in charge, face mask held by the patient for pre-oxygenation

Intervention Type PROCEDURE

one anaesthetist is in charge of the simulated patient (volunteer), face mask held by the volunteer for pre-oxygenation for ORI which has reached a plateau value for more than 10 seconds All the usual supplies and medicines are available and in the same place as usual.

The sequence is as follows:

1. Patient entering the operating room, patient lying on the operating table, start of the stopwatch
2. Opening of the computerized anaesthesia file
3. Monitoring (ECG, non-invasive blood pressure, SaO2) of the patient
4. Preparation of the hypnotic (propofol or thiopental, as desired)
5. Preparation of curare (succinylcholine or rocuronium, as desired)
6. Face mask held by the patient for pre-oxygenation
7. Waiting for an ORI which has reached a plateau value for more than 10 seconds
8. Conditions for general anaesthesia met for the participating anaesthetist
9. "End of simulation", stopwatch stop

scenario 3: one anaesthetist in charge, THRIVE used for pre-oxygenation

Intervention Type PROCEDURE

All the usual supplies and medicines are available and in the same place as usual.

The sequence is as follows:

1. Patient entering the operating room, patient lying on the operating table, start of the stopwatch
2. Opening of the computerized anaesthesia file
3. Monitoring (ECG, non-invasive blood pressure, SaO2) of the patient
4. Preparation of the hypnotic (propofol or thiopental, as desired)
5. Preparation of curare (succinylcholine or rocuronium, as desired)
6. THRIVE for pre-oxygenation
7. Waiting for an ORI which has reached a plateau value for more than 10 seconds
8. Conditions for general anaesthesia met for the participating anaesthetist
9. "End of simulation", stopwatch stop

scenario 4: one anaesthetist and one nurse anaesthetist in charge, the face mask is held by the anaesthetist or the nurse anaesthetist

Intervention Type PROCEDURE

All the usual supplies and medicines are available and in the same place as usual.

The sequence is as follows:

1. Patient entering the operating room, patient lying on the operating table, start of the stopwatch
2. Opening of the computerized anaesthesia file
3. Monitoring (ECG, non-invasive blood pressure, SaO2) of the patient
4. Preparation of the hypnotic (propofol or thiopental, as desired)
5. Preparation of curare (succinylcholine or rocuronium, as desired)
6. Pre-oxygenation of the patient with the face mask held by the participating anaesthetist or nurse anaesthetist
7. Waiting for an ORI which has reached a plateau value for more than 10 seconds
8. Conditions for general anaesthesia met for the participating anaesthetist
9. "End of simulation", stopwatch stop

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

scenario 1 : pre-oxygenation with a face mask held by the anaesthetist

the face mask is held by the anaesthetist (reference technique) to obtain effective pre-oxygenation for Oxygen Reserve Index (ORI) which has reached a plateau value for more than 10 seconds. All the usual supplies and medicines are available and in the same place as usual.

The sequence is as follows:

1. Patient lying on the operating table, start of the stopwatch
2. Opening of the computerized anaesthesia file
3. Monitoring (ECG, non-invasive blood pressure, SaO2) of the patient
4. Preparation of the hypnotic (propofol or thiopental, as desired)
5. Preparation of curare (succinylcholine or rocuronium, as desired)
6. Pre-oxygenation of the patient with the face mask held by the participating anaesthetist
7. Waiting for an ORI which has reached a plateau value for more than 10 seconds
8. Conditions for general anaesthesia met for the participating anaesthetist
9. "End of simulation", stopwatch stop

Intervention Type PROCEDURE

scenario 2: one anaesthetist in charge, face mask held by the patient for pre-oxygenation

one anaesthetist is in charge of the simulated patient (volunteer), face mask held by the volunteer for pre-oxygenation for ORI which has reached a plateau value for more than 10 seconds All the usual supplies and medicines are available and in the same place as usual.

The sequence is as follows:

1. Patient entering the operating room, patient lying on the operating table, start of the stopwatch
2. Opening of the computerized anaesthesia file
3. Monitoring (ECG, non-invasive blood pressure, SaO2) of the patient
4. Preparation of the hypnotic (propofol or thiopental, as desired)
5. Preparation of curare (succinylcholine or rocuronium, as desired)
6. Face mask held by the patient for pre-oxygenation
7. Waiting for an ORI which has reached a plateau value for more than 10 seconds
8. Conditions for general anaesthesia met for the participating anaesthetist
9. "End of simulation", stopwatch stop

Intervention Type PROCEDURE

scenario 3: one anaesthetist in charge, THRIVE used for pre-oxygenation

All the usual supplies and medicines are available and in the same place as usual.

The sequence is as follows:

1. Patient entering the operating room, patient lying on the operating table, start of the stopwatch
2. Opening of the computerized anaesthesia file
3. Monitoring (ECG, non-invasive blood pressure, SaO2) of the patient
4. Preparation of the hypnotic (propofol or thiopental, as desired)
5. Preparation of curare (succinylcholine or rocuronium, as desired)
6. THRIVE for pre-oxygenation
7. Waiting for an ORI which has reached a plateau value for more than 10 seconds
8. Conditions for general anaesthesia met for the participating anaesthetist
9. "End of simulation", stopwatch stop

Intervention Type PROCEDURE

scenario 4: one anaesthetist and one nurse anaesthetist in charge, the face mask is held by the anaesthetist or the nurse anaesthetist

All the usual supplies and medicines are available and in the same place as usual.

The sequence is as follows:

1. Patient entering the operating room, patient lying on the operating table, start of the stopwatch
2. Opening of the computerized anaesthesia file
3. Monitoring (ECG, non-invasive blood pressure, SaO2) of the patient
4. Preparation of the hypnotic (propofol or thiopental, as desired)
5. Preparation of curare (succinylcholine or rocuronium, as desired)
6. Pre-oxygenation of the patient with the face mask held by the participating anaesthetist or nurse anaesthetist
7. Waiting for an ORI which has reached a plateau value for more than 10 seconds
8. Conditions for general anaesthesia met for the participating anaesthetist
9. "End of simulation", stopwatch stop

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* major
* female
* affiliated to a social security scheme or beneficiary of such a scheme
* having voluntarily and informedly agreed to participate in the study.
* non-smoker
* free from pulmonary, cardiac and neurological pathologies
* have a normal functional respiratory test at baseline.

Exclusion Criteria

* refusal to participate in the study
* non-French speaking volunteer
* obesity defined by a body mass index greater than 30 kilogram/meter² (kg/m²)
* current pregnancy
* Volunteer in period of exclusion from further research
* Person under guardianship, curatorship or any other administrative or judicial measure of deprivation of rights and liberty
Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hospices Civils de Lyon

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hopital Femme Mère Enfant

Bron, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2021-A00047-34

Identifier Type: OTHER

Identifier Source: secondary_id

69HCL20_1116

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.